Stem Cells and Nanosilver Saved Diabetic Foot
Keywords:
Stem cells, Nanosilver, Treatment, diabetic foot.Abstract
We showed a case of 65 years-old Iraqi male who suffered from uncontrolled type 2 diabetes mellitus for 13 years. He developed an ulcer in his left big toe for five days in March 2021. The clinical assessment proved an infected stage 3 diabetic ulcer. We discussed the patient's condition with the patient/family, and they agreed and then consented. The therapy continued for one month and incorporated four sessions of surgical debridement, application of stem cells, and nanosilver. The patient/family noticed marked wound healing documented by the camera. Stem cells and Nanosilver therapy saved diabetic foot, and we advise it.
References
Hamad AM, Alhiti HAR. Non-obstructive Azoospermia Aided by Autologous Stem Cells. J Med Case Repo. 2022; 4(1): 1-3.
Hamad AM, Alhiti HAR. Stem Cell Therapy Modulates Cerebral Palsy: Case Report. J. Arch Med Case Repo Case Stud. 2022; 5(5): 1-3. doi: 10.31579/2692-9392/118.
Alhiti? HAR. Nanosilver plus Bacteriophages Cured COVID. Aditum J Clin Biomed Res. 2022; 4(1): 1-2.
Alhiti? HAR. Effective, Proven, and Updated Cure of COVID. Glob J Infect Immune Ther. 2022; 4(1): 118.
Luaibi O, Zenad MM, Hammadi AM, Hasso SA. Uses of Stem Cells in Treatment of Experimentally Induced Diabetes Mellitus in Dogs. Int J Scientific Res. 2012; 3: 35-38. doi: 10.15373/ 22778179/June2014/172.
Huang C, Hsueh YY, Huang WC, Patel S, Li S. Multipotent vascular stem cells contribute to neurovascular regeneration of peripheral nerve. Stem Cell Res Ther. 2019; 10: 234.
Hammad A, Alhiti HAR, Guma M, Mansour A, Al-Faham M, Al-Wasitty A. Inhalational Bacteriophage and Nanosilver Effectiveness on nCOVID-19: A Case Report. J Med Res Surg. 2021; 2(3): 1-5. doi: 10.52916/jmrs214046.
Hamad AM, Alhiti HAR, Guma MA. Baghdad's first success in Bone Marrow Aspirate Concentrate procedure. J Fac Med Or. 2021; 5(2): 695-700. doi: 10.51782/jfmo.v5i2.126.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Journal of Liaquat University of Medical & Health Sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Submission of a manuscript to the journal implies that all authors have read and agreed to the content of the undertaking form or the Terms and Conditions.
When an article is accepted for publication, the author(s) retain the copyright and are required to grant the publisher the right of first publication and other non-exclusive publishing rights to JLUMHS.
Articles published in the Journal of Liaquat University of Medical & health sciences are open access articles under a Creative Commons Attribution-Noncommercial - Share Alike 4.0 License. This license permits use, distribution and reproduction in any medium; provided the original work is properly cited and initial publication in this journal. This is in accordance with the BOAI definition of open access. In addition to that users are allowed to remix, tweak and build upon the work non-commercially as long as appropriate credit is given and the new creations are licensed under the identical terms. Or, in certain cases it can be stated that all articles and content there in are published under creative commons license unless stated otherwise.